This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Consiglio Nazionale Delle Richerche, Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione-Istituto Dermopatico Dell'immacolata, Università Degli Studi Di Roma "La Sapienza". Active years: 2012.
Company Filing History:
1 out of 31 
1 out of 2 
1 out of 63 
Years Active: 2012
Title: Simonetta Soro: Innovator in Proangiogenic Peptide Research
Introduction
Simonetta Soro is a notable inventor based in Rome, Italy. She has made significant contributions to the field of pharmacology, particularly in the development of peptides with proangiogenic activity. Her work has implications for various medical applications, especially in enhancing vascular growth.
Latest Patents
Simonetta Soro holds a patent for a peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1, which exhibits proangiogenic activity. The patent describes a sequence peptide isolated in the domain II type-immunoglobulin (Type-Ig) of the Vascular Endothelial Growth Factor receptor 1 (VEGF-1). This peptide is usable for the preparation of pharmacological agents aimed at promoting angiogenesis.
Career Highlights
Throughout her career, Simonetta has worked with esteemed organizations such as the Italian Province of the Congregation of the Sons of the Immaculate Conception - Dermopathic Institute of the Immaculate and the National Research Council of Italy. Her research has been pivotal in advancing the understanding of vascular biology and therapeutic applications.
Collaborations
Simonetta has collaborated with notable colleagues, including Stefania D'Atri and Giovanna Zambruno. Their joint efforts have contributed to the advancement of research in the field of proangiogenic peptides.
Conclusion
Simonetta Soro's innovative work in peptide research highlights her role as a key figure in the development of pharmacological agents with proangiogenic properties. Her contributions continue to influence the field of vascular biology and therapeutic development.